CVS Health (CVS) – Analysts’ Recent Ratings Changes

CVS Health (NYSE: CVS) recently received a number of ratings updates from brokerages and research firms:

• 12/29/2025 – CVS Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – CVS Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/17/2025 – CVS Health had its price target raised by analysts at JPMorgan Chase & Co. from $93.00 to $101.00. They now have an “overweight” rating on the stock.
• 12/15/2025 – CVS Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/12/2025 – CVS Health had its price target raised by analysts at Sanford C. Bernstein from $86.00 to $87.00. They now have a “market perform” rating on the stock.
• 12/10/2025 – CVS Health had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald.
• 12/10/2025 – CVS Health had its “overweight” rating reaffirmed by analysts at Piper Sandler. They now have a $101.00 price target on the stock, up previously from $99.00.
• 12/10/2025 – CVS Health had its price target raised by analysts at Morgan Stanley from $89.00 to $93.00. They now have an “overweight” rating on the stock.
• 12/10/2025 – CVS Health had its price target raised by analysts at Barclays PLC from $87.00 to $93.00. They now have an “overweight” rating on the stock.
• 12/10/2025 – CVS Health had its “outperform” rating reaffirmed by analysts at UBS Group AG.
• 12/10/2025 – CVS Health had its price target raised by analysts at UBS Group AG from $96.00 to $97.00. They now have a “buy” rating on the stock.
• 12/10/2025 – CVS Health was given a new $100.00 price target on by analysts at Truist Financial Corporation.
• 12/10/2025 – CVS Health had its price target raised by analysts at TD Cowen from $100.00 to $105.00. They now have a “buy” rating on the stock.
• 12/10/2025 – CVS Health had its price target raised by analysts at The Goldman Sachs Group, Inc. from $93.00 to $95.00. They now have a “buy” rating on the stock.
• 12/10/2025 – CVS Health had its price target raised by analysts at Mizuho from $88.00 to $95.00. They now have an “outperform” rating on the stock.
• 12/10/2025 – CVS Health had its price target raised by analysts at Truist Financial Corporation from $95.00 to $98.00. They now have a “buy” rating on the stock.
• 12/10/2025 – CVS Health had its price target raised by analysts at Robert W. Baird from $82.00 to $92.00. They now have an “outperform” rating on the stock.
• 12/8/2025 – CVS Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/8/2025 – CVS Health had its price target raised by analysts at Wolfe Research from $85.00 to $100.00. They now have an “outperform” rating on the stock.
• 12/4/2025 – CVS Health had its price target raised by analysts at Sanford C. Bernstein from $77.00 to $86.00. They now have a “market perform” rating on the stock.
• 12/4/2025 – CVS Health had its “outperform” rating reaffirmed by analysts at Royal Bank Of Canada.
• 12/3/2025 – CVS Health had its “buy” rating reaffirmed by analysts at UBS Group AG.
• 12/1/2025 – CVS Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/24/2025 – CVS Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/17/2025 – CVS Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/13/2025 – CVS Health had its price target lowered by analysts at Wells Fargo & Company from $103.00 to $102.00. They now have an “overweight” rating on the stock.
• 11/11/2025 – CVS Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/5/2025 – CVS Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/4/2025 – CVS Health had its price target raised by analysts at Argus from $80.00 to $91.00. They now have a “buy” rating on the stock.
• 11/3/2025 – CVS Health had its price target raised by analysts at TD Cowen from $99.00 to $100.00. They now have a “buy” rating on the stock.

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.